According to Celltrion, STEQEYMA is expected to be marketed in the United States beginning in February 2025. DISCLAIMER: Because of the generality of this update, the information provided herein may ...
The document follows the agency’s first digital health advisory meeting and a final guidance on postmarket updates to AI ...
Do not sell or donate the recalled products, and do not feed the recalled product to pets or any other animals. Wash and ...
Robert F. Kennedy Jr.'s plan to combat obesity and chronic diseases by targeting high-fructose corn syrup could mean changes ...
Nanoleaf has made an unexpected leap at CES 2025 with the release of its first-ever LED face mask. Typically known for its ...
The U.S. FDA has released a new draft guidance for drugmakers to aid them in developing new treatments for obesity. The new ...
Hosted on MSN55m
FDA grants ODD to Tempest’s hepatocellular carcinoma treatmentThe US Food and Drug Administration has granted orphan drug designation (ODD) to Tempest Therapeutics' oral, selective ...
The agency issued final guidance that it estimated could reduce lead exposure from processed baby foods by about 20% to 30%.
Nanoleaf revealed three new smart lights at CES 2025, as well as an FDA-certified LED light therapy face mask.
Amid recent backlash stemming from market withdrawals and trial delays, the FDA seeks to further clarify its requirements for ...
GlobalData has named heart failure as the next disease to feel the sales-boosting power of GLP-1 drugs. The analysts expect ...
The final guidance covers packaged processed foods that are represented or purported to be for babies and young children less ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback